DISTURBANCES IN MINERAL METABOLISM AFTER SUCCESSFUL RENAL-TRANSPLANTATION
- 1 January 1985
- journal article
- research article
- Vol. 11 (3) , 167-172
Abstract
Abnormalities of mineral metabolism remain a clinical problem after successful renal transplantation. These disturbances may be the result of derangements in divalent Fe, parathyroid hormone (PTH) and/or vitamin D metabolism. Serum Ca, phosphorus, PTH and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels and fractional intestinal Ca absorption (.alpha.) were measured in 6 patients before and after successful transplantation (early, .ltoreq. 6 mo.). There were reexamined later (late, .gtoreq. 24 mo. after transplantation). The patients exhibited decreased serum levels of 1,25(OH)2D and .alpha. before the renal transplantation. In the early stages, renal transplantation reduced serum P from 5.55 .+-. (SD) 1.96 to 2.96 .+-. 0.95 mg/dl (P < 0.02); this was accompanied by a rise in serum 1,25(OH)2D from 8.7 .+-. 1.5 to 26.3 .+-. 8.4 pg/ml (P < 0.005). The calcemic response to PTH infusion became normal, since the increment in serum Ca rose from 0.45 .+-. 0.21 mg/dl before transplantation to 1.03 .+-. 0.18 mg/dl early after transplantation. Although, the mean value for .alpha. increased significantly from 0.263 .+-. 0.048 to 0.402 .+-. 0.175 (P < 0.05), .alpha. was subnormal in 3 patients (.alpha. < 0.37). Urinary Ca was high in 3 patients, and it exceeded absorbed Ca (from intestines) in 4 patients (indicative of negative Ca balance). Serum PTH fell significantly but remained above normal. It was hoped that late after transplantation, when patients were maintained on smaller doses of oral glucocorticoids, these abnormalities would be ameliorated. Hypercalciuria was found in 2 of 3 patients. Serum PTH remained elevated in all 3 patients despite adequate creatinine clearance. Fasting hypercalciuria (> 0.1 mg/100 ml glomerular filtration) was encountered in 2 of 3 patients. Apparently parathyroid stimulation, hypercalciuria and subnormal intestinal Ca absorption may persist in some patients after successful renal transplantation in the face of a rise in serum 1,25(OH)2D and improved skeletal responsiveness to PTH. The exact cause of these disturbances remains to be elucidated.This publication has 12 references indexed in Scilit:
- Effects of Short Term Glucocorticoid Administration in Primary Hyperparathyroidism: Comparison to Sarcoidosis*Journal of Clinical Endocrinology & Metabolism, 1982
- Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiencyKidney International, 1982
- A Lack of Unique Pathophysiologic Background for Nephrolithiasis of Primary Hyperparathyroidism*Journal of Clinical Endocrinology & Metabolism, 1981
- Tumoral calcinosis: Evidence for concurrent defects in renal tubular phosphorus transport and in 1α,25-dihydroxycholecalciferol synthesisCalcified Tissue International, 1980
- Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.Journal of Clinical Investigation, 1979
- Intestinal Calcium Absorption in Exogenous HypercortisonismJournal of Clinical Investigation, 1977
- Role of Phosphate in the Genesis of Secondary Hyperparathyroidism of Renal FailureNephron, 1977
- Skeletal resistance to the calcemic action of parathyroid hormone in uremia: Role of 1,25(OH)2D3Kidney International, 1976
- Skeletal Resistance to Parathyroid Hormone in Renal FailureAnnals of Internal Medicine, 1973
- Modifications of a specific assay for hydroxyproline in urineAnalytical Biochemistry, 1967